Unlike in basal‐like breast cancer, CAPN2 expression showed minimal impact on the risk of other subtypes of breast cancer, highlighting the potential significance of calpain 2 as a critical target only in TNBC (Figure S1A). This evidence concerns the gene CAPN2 and breast carcinoma.